ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

BW Keene, CE Atkins, JD Bonagura… - Journal of veterinary …, 2019 - Wiley Online Library
This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises
guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also …

ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs

C Reinero, LC Visser, HB Kellihan… - Journal of veterinary …, 2020 - Wiley Online Library
Pulmonary hypertension (PH), defined by increased pressure within the pulmonary
vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of …

[HTML][HTML] Management of chronic congestive heart failure caused by myxomatous mitral valve disease in dogs: A narrative review from 1970 to 2020

M Bagardi, V Zamboni, C Locatelli, A Galizzi, S Ghilardi… - Animals, 2022 - mdpi.com
Simple Summary Myxomatous mitral valve disease (MMVD) is the most common acquired
cardiovascular disease in dogs. The progression of the disease and the increasing severity …

Management of cardiac emergencies in small animals

TC DeFrancesco - Veterinary Clinics: Small Animal Practice, 2013 - vetsmall.theclinics.com
Cardiac emergencies include a variety of different diseases, including congestive heart
failure (HF), cardiac tamponade, arrhythmogenic disease, and thromboembolic disease …

Эндокардиоз атриовентрикулярных клапанов сердца у собак

АА Руденко, ЮА Ватников, ПА Руденко… - 2022 - elibrary.ru
В монографии на основе новейших прикладных и фундаментальных достижений
ветеринарной медицины рассматривается наиболее распространенная патология …

Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease

M Baron Toaldo, G Romito… - Journal of veterinary …, 2018 - Wiley Online Library
Background The prognostic relevance of left atrial (LA) morphological and functional
variables, including those derived from speckle tracking echocardiography (STE), has been …

[HTML][HTML] Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

S Klein, I Nolte, JL Granados-Soler, P Lietz… - BMC veterinary …, 2022 - Springer
Background Dogs with degenerative mitral valve disease are commonly presented to small
animal clinicians. Diagnosis, clinical staging, and therapeutic design are based on a …

Management of acute heart failure in cats

L Ferasin, T DeFrancesco - Journal of Veterinary Cardiology, 2015 - Elsevier
Acute heart failure in cats represents a complex clinical situation in feline practice and this
review has been designed to focus on the description of acute heart failure in cats, the …

Short‐term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure

J Häggström, PF Lord, K Höglund… - Journal of veterinary …, 2013 - Wiley Online Library
Background Pimobendan and benazepril are frequently used with diuretics to treat dogs in
congestive heart failure (CHF) caused by myxomatous mitral valve disease (MMVD). Aim To …

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease

AK McManamey, TC DeFrancesco… - Journal of Veterinary …, 2023 - Wiley Online Library
Background Pimobendan is an important therapy for dogs with myxomatous mitral valve
disease (MMVD). The pharmacokinetics are reported in healthy dogs but not in dogs with …